Meeting
2014 ASCO Annual Meeting
PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
Authors
Sascha Ansen
Department I of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany
Sascha Ansen , Anne Maria Schultheis , Martin Hellmich , Thomas Zander , Michael Brockmann , Erich Stoelben , Harry J.M. Groen , Wim Timens , Reinhard Buettner , Roman K. Thomas , Sven Perner , Juergen Wolf
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 7517)
DOI
10.1200/jco.2014.32.15_suppl.7517
Abstract #
7517
Poster Bd #
10
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2019 ASCO Annual Meeting
Mutational landscapes and PD-L1 expression in non-small cell lung cancer.
First Author: Kang Zhang
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera